Patent Assignment
Reel/Frame 060111/0310
Assignment of Assignor's Interest
Recorded: 2022-06-06
Pages: 4
Assignor
CHARLES RIVER LABORATORIES, INC.
Executed: 2021-09-09
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Heteroaryl Plasma Kallikrein Inhibitors
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 6, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 060111/0256 →
Assignment of Assignor's Interest
Jun 6, 2022
From: PAPAIOANNOU, NIKOLAOS; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060111/0267 →
Assignment of Assignor's Interest
Jun 6, 2022
From: ELLARD, JOHN MARK; RAE, ALASTAIR
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 060111/0276 →
Assignment of Assignor's Interest
Jun 6, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 060111/0297 →
Assignment of Assignor's Interest
Jun 6, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060111/0330 →
Assignment of Assignor's Interest
Jun 6, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 060285/0748 →